Management of small-cell bronchogenic carcinoma.
D006585:Altretamine / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D001932:Brain Neoplasms; D002283:Carcinoma, Bronchogenic / Q000175:diagnosis / Q000628:therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000628:therapy*; D008466:Mechlorethamine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D010996:Pleural Effusion; D011379:Prognosis; D014683:Vena Cava, Superior
D000903:Antibiotics, Antineoplastic; D008466:Mechlorethamine; D003520:Cyclophosphamide; D006585:Altretamine; D008727:Methotrexate